Intratendon delivery of leukocyte-rich platelet-rich plasma at early stage promotes tendon repair in a rabbit Achilles tendinopathy model

被引:17
|
作者
Li, Sihao [1 ]
Wu, Yifan [2 ]
Jiang, Guangyao [1 ]
Tian, Xiulian [3 ]
Hong, Jianqiao [1 ]
Chen, Shiming [4 ]
Yan, Ruijian [1 ]
Feng, Gang [1 ]
Cheng, Zhiyuan [5 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, 88 Jie Fang Rd, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Zhejiang Univ Hosp, Dept Surg, Hangzhou, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou, Zhejiang, Peoples R China
[4] Shaoxing Second Hosp, Dept Surg, Shaoxing, Peoples R China
[5] Zhejiang Univ, Coll Informat Sci & Elect Engn, Inst Microelect & Nanoelect, Key Lab Adv Micro Nano Elect Devices & Smart Syst, Hangzhou, Peoples R China
关键词
early stage; leukocyte; platelet-rich plasma; rabbit model; repair; tendinopathy; GROWTH-FACTOR; P-PRP; INFLAMMATION; INJECTION; FIBROBLAST; MECHANISMS; DIAGNOSIS; INJURY;
D O I
10.1002/term.3006
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Tendinopathy is a great obstacle in clinical practice due to its poor regenerative capacity. The influence of different stages of tendinopathy on effects of leukocyte-rich platelet-rich plasma (Lr-PRP) has not been elucidated. The aim of this study is to investigate the optimal time point for delivery of Lr-PRP on tendinopathy. A tendinopathy model was established by local collagenase injection on the rabbit Achilles tendon. Then after collagenase induction, following treatments were applied randomly on the lesion: (a) 200 mu l of Lr-PRP at 1 week (PRP-1 group), (b) 200 mu l of saline at 1 week (Saline-1 group), (c) 200 mu l of Lr-PRP at 4 weeks (PRP-2 group), and (d) 200 mu l of saline at 4 weeks (Saline-2 group). Six weeks after collagenase induction, outcomes were assessed by magnetic resonance imaging, cytokine quantification, gene expression, histology, and transmission electron microscopy. Our results demonstrated that PRP-1 group had the least cross-sectional area and lesion percent of the involved tendon, as well as the lowest signal intensity in magnetic resonance imaging among all groups. However, the PRP-2 group showed larger cross-sectional area than saline groups. Enzyme-linked immunosorbent assay indicated that PRP-1 group had a higher level of interleukin-10 but lower level of interleukin-6 when compared with PRP-2 and saline groups. Meanwhile, the highest expression of collagen (Col) 1 in PRP-1 and Col 3, matrix metalloproteinase (MMP)-1, and MMP-3 in PRP-2 was found. Histologically, the PRP-1 showed better general scores than PRP-2, and no significant difference was found between the PRP-2 and saline groups. For transmission electron microscopy, PRP-1 had the largest mean collagen fibril diameter, and the PRP-2 group showed even smaller mean collagen fibril diameter than saline groups. In conclusion, intratendon delivery of Lr-PRP at early stage showed beneficial effect for repair of tendinopathy but not at late stage. For translation of our results to clinical circumstances, further studies are still needed.
引用
收藏
页码:452 / 463
页数:12
相关论文
共 50 条
  • [41] Single injection of platelet-rich plasma in a rat Achilles tendon tear model
    Parafioriti, Antonina
    Armiraglio, Elisabetta
    Del Bianco, Silvia
    Tibalt, Elisabetta
    Oliva, Francesco
    Berardi, Anna C.
    MLTJ-MUSCLES LIGAMENTS AND TENDONS JOURNAL, 2011, 1 (02): : 41 - 47
  • [42] Platelet Rich Placebo? Evidence for Platelet Rich Plasma in the Treatment of Tendinopathy and Augmentation of Tendon Repair
    Hall, Michael P.
    Ward, James P.
    Cardone, Dennis A.
    BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2013, 71 (01): : 54 - 59
  • [43] Leukocyte-poor platelet-rich plasma and leukocyte-rich platelet-rich plasma promote myoblast proliferation through the upregulation of cyclin A, cdk1, and cdk2
    Chen, Li-Siou
    Chen, Chih-Kuang
    Pang, Jong-Hwei Su
    Lin, Li-Ping
    Yu, Tung-Yang
    Tsai, Wen-Chung
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2024, 42 (01) : 32 - 42
  • [44] Comparison of Effects of Leukocyte-RICH and Leukocyte-Poor Platelet-RICH Plasma on PAIN and Functionality in Patients with Lateral Epicondylitis
    Calis, Havva Talay
    Yerlikaya, Melek
    Sutbeyaz, Serap
    Sayan, Hatice
    Ozkan, Nurdan
    Koc, Ali
    Karakukcu, Cigdem
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] Differences in the effectiveness of leukocyte-rich platelet-rich plasma compared with leukocyte-poor platelet-rich plasma in the treatment of rotator cuff surgery: an umbrella review of meta-analyses
    Tang, Peiyuan
    Rahmati, Masoud
    Xiao, Wenfeng
    Wen, Ting
    Yon, Dong Keon
    Smith, Lee
    Su, Jingyue
    Yang, Shengwu
    Li, Yusheng
    Deng, Zhenhan
    JOURNAL OF ORTHOPAEDICS AND TRAUMATOLOGY, 2024, 25 (01)
  • [46] Effect of Platelet-Rich Plasma Augmentation on Endoscopy-Assisted Percutaneous Achilles Tendon Repair
    Hung, Chun-Yu
    Lin, Shih-Jie
    Yeh, Chia-Yi
    Yeh, Wen-Ling
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [47] A Prospective Study of Platelet-Rich Plasma as Biological Augmentation for Acute Achilles Tendon Rupture Repair
    Zou, Jian
    Mo, Xiaolian
    Shi, Zhongmin
    Li, Tanzhu
    Xue, Jianfeng
    Mei, Guohua
    Li, Xiaolin
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [48] Platelet-Rich Plasma Injection for Chronic Achilles Tendinopathy A Randomized Controlled Trial
    de Vos, Robert J.
    Weir, Adam
    van Schie, Hans T. M.
    Bierma-Zeinstra, Sita M. A.
    Verhaar, Jan A. N.
    Weinans, Harrie
    Tol, Johannes L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (02): : 144 - 149
  • [49] Role of Mechanical Loading for Platelet-Rich Plasma-Treated Achilles Tendinopathy
    Neph, Alyssa
    Schroeder, Allison
    Enseki, Keelen R.
    Everts, Peter A.
    Wang, James H-C
    Onishi, Kentaro
    CURRENT SPORTS MEDICINE REPORTS, 2020, 19 (06) : 209 - 216
  • [50] Platelet-rich plasma injections as a treatment for Achilles tendinopathy and plantar fasciitis in athletes
    Sneed, Dustin
    Wong, Carmen
    PM&R, 2023, 15 (11) : 1493 - 1506